Contrasting effects of non-starch polysaccharide and resistant starch-based diets on the disposition and excretion of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), in a rat model
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
It has commonly been believed that increasing fibre in the diet should reduce the
incidence of cancers, especially those of the colon and rectum. The earliest definitions
of dietary fibre restricted the term to plant cell walls in which non-starch polysaccharides
are key chemical components. However, new definitions encompass a wider range of materials,
including starches resistant to digestion in the colon (resistant starches). Nevertheless,
most definitions require that "dietary fibres" show physiological effects considered
beneficial against cancer, including enhanced laxation and faecal bulking. On theoretical
grounds, such properties might be expected to dilute the concentration of any carcinogen
present and move it more rapidly through the colon, thereby reducing bioavailability.
We have compared the properties of two dietary fibre preparations that are primarily
non-starch polysaccharides with two resistant starch preparations for effects on carcinogen
disposition in a rodent model. Although both preparations enhanced laxation and faecal
bulking, only the non-starch polysaccharide preparation reduced carcinogen biovailability.
Indeed, carcinogen biovailability was significantly enhanced by resistant starch.
We suggest that there may be fundamental differences in the manner by which non-starch
polysaccharides or resistant starches affect carcinogen disposition, and express concern
that the events seen with the resistant starches [RS] are unlikely to be beneficial
with respect to protection against cancer by exogenous carcinogens. Furthermore, the
data reveal that the observation of enhanced laxation and faecal bulking does not
necessarily imply a reduction in carcinogen bioavailability.